Study reveals hidden inactive form of p38a protein

p38a protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions.

CymaBay meets primary, key secondary endpoints in PhIII liver trial

CymaBay Therapeutics’ lead candidate met the primary endpoint and key secondary endpoints in a Phase III trial for a liver disease, setting the stage for

September 8, 2023

Two Noninvasive Ventilation Modes Win for Riskiest NICU Newborns

The known advantages of certain noninvasive respiratory support techniques prevailed for extremely preterm newborns following extubation and for those with more severe respiratory failure, subgroup

July 7, 2023

Health insurers are covering fewer telehealth companies, Talkspace says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.